NCT07213622
The Use of Smart Glasses for Saphenous Nerve Adductor Canal Block
Enrolling by Invitation
NAAges 18+InterventionalTreatmentMetroHealth Medical CenterInvestigator-initiated
~100 participants
Updated 2025-10-09 on ClinicalTrials.gov
What's tested:Smartglasses
At a glance
Recruiting sites
0 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Time from needle insertion to complete local anesthetic injection
Measured over Until the end of the study
Conditions
Where it's being run
1 sites across 1 statesOhio1
Who to contact
This trial hasn't published a contact. View it on ClinicalTrials.gov
Do you actually qualify for this trial?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Eligibility criteria
Inclusion
patients 18 years or greater
undergoing total knee arthroplasty
Exclusion
Patients with local infection at nerve block site
BMI \>40
Patients who are at risk for local anesthesia systemic toxicity due to intraoperative local dose
Patients with nerve damage to the femoral or saphenous nerve
Documented history of mental or cognitive disabilities in EMR
Non-English speaking patient
Pregnant Women (self-reported)
Prisoners
Patients under the age of 18
What this trial measures
- Time from needle insertion to complete local anesthetic injectionUntil the end of the study